Skip to content

13G/A filed by Paradigm Biocapital Advisors LP

Paradigm Biocapital Advisors LP and 3 other reporting persons reported 8,257,672 VRDN shares, 7.3% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-11-16 21:12:00 UTC.

Accession
0001104659-26-128315
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

Stake

Shares
8,257,672
Percent of class
7.3%
Event date
2026-09-30

How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.

Read for the filer group Paradigm Biocapital Advisors LP.

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
Paradigm BioCapital Advisors LPPN8,257,67208,257,67208,257,6727.3%
Paradigm BioCapital Advisors GP LLCOO8,257,67208,257,67208,257,6727.3%
Senai Asefaw, M.D.IN8,257,67208,257,67208,257,6727.3%
Paradigm BioCapital International Fund Ltd.CO7,278,10507,278,10507,278,1056.4%